Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region
2011

HIV, HBV, and HCV Co-Infection Prevalence among Drug Users in China and Myanmar

Sample size: 721 publication 10 minutes Evidence: high

Author Information

Author(s): Zhou Yan-Heng, Liu Feng-Liang, Yao Zhi-Hong, Duo Lin, Li Hong, Sun Yi, Zheng Yong-Tang

Primary Institution: Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China

Hypothesis

What is the prevalence of HIV, HBV, and HCV co-infection among intravenous drug users in the China-Myanmar border region?

Conclusion

Co-infection with HIV and HCV and/or HBV is highly prevalent among the IDUs in the China-Myanmar border region, with higher rates in Chinese IDUs compared to Burmese IDUs.

Supporting Evidence

  • HCV infection was the most prevalent among Chinese IDUs at 69.0%.
  • HBV infection was found in 51.6% of Chinese IDUs compared to 43.1% of Burmese IDUs.
  • 33.7% of Chinese IDUs were HIV positive compared to 27.0% of Burmese IDUs.
  • Co-infection rates were higher among Chinese IDUs for both HIV-HBV and HIV-HCV.
  • Triple infection rates were 19.1% in China and 10.4% in Myanmar.

Takeaway

This study looked at drug users in China and Myanmar and found that many of them have multiple infections, especially with HIV and hepatitis viruses.

Methodology

721 intravenous drug users were tested for HIV, HBV, and HCV serological status, and statistical analysis was performed to evaluate differences between Chinese and Burmese IDUs.

Potential Biases

Potential bias in self-reported drug use and health status.

Limitations

The study may not represent all IDUs in the region due to the specific recruitment methods used.

Participant Demographics

403 Chinese IDUs and 318 Burmese IDUs, predominantly male, with a median age of around 32 years.

Statistical Information

P-Value

P<0.001 for HCV prevalence, P<0.05 for HBV prevalence, P<0.005 for HIV-HBV co-infection.

Confidence Interval

95% CI: 66.6%–86.7% for HCV infection in Yunnan.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016349

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication